Compare CGNX & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGNX | HIMS |
|---|---|---|
| Founded | 1981 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 7.0B |
| IPO Year | 1994 | 2019 |
| Metric | CGNX | HIMS |
|---|---|---|
| Price | $53.97 | $27.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 15 |
| Target Price | ★ $57.91 | $30.46 |
| AVG Volume (30 Days) | 1.5M | ★ 29.9M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | ★ 9.68 | N/A |
| EPS | ★ 0.68 | 0.51 |
| Revenue | N/A | ★ $2,347,637,000.00 |
| Revenue This Year | $9.52 | $19.82 |
| Revenue Next Year | $8.63 | $19.23 |
| P/E Ratio | $80.72 | ★ $57.15 |
| Revenue Growth | N/A | ★ 59.00 |
| 52 Week Low | $26.14 | $13.74 |
| 52 Week High | $59.88 | $70.43 |
| Indicator | CGNX | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 54.83 | 58.98 |
| Support Level | $40.76 | $18.62 |
| Resistance Level | $59.11 | $31.86 |
| Average True Range (ATR) | 1.74 | 2.29 |
| MACD | -0.07 | 0.49 |
| Stochastic Oscillator | 28.62 | 69.56 |
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. Geographically, it operates in United states, Europe, Greater China and others. Cognex generates the maximum proportion of its sales in the United States and Europe.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.